Immunotherapy and vaccination against infectious diseases
Summary Due to the overuse of antibiotics, infections, in particular those caused by multidrug-resistant bacteria, are becoming more and more frequent. Despite the worldwide introduction of antibiotic therapy, vaccines and constant improvements in hygiene, the burden of multidrug-resistant bacterial infections is increasing and is expected to rise in the future. The development of monoclonal therapeutic antibodies and specific immunomodulatory drugs represent new treatment options in the fight against infectious diseases. This article provides a brief overview of recent advances in immunomodulatory therapy and other strategies in the treatment of infectious disease..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:133 |
|---|---|
| Enthalten in: |
Wiener klinische Wochenschrift - 133(2020), 13-14 vom: 16. Dez., Seite 714-720 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ebbers, Meinolf [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
Bacterial infections |
|---|
| Anmerkungen: |
© The Author(s) 2020 |
|---|
| doi: |
10.1007/s00508-020-01746-2 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2126735982 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2126735982 | ||
| 003 | DE-627 | ||
| 005 | 20230505120958.0 | ||
| 007 | tu | ||
| 008 | 230505s2020 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00508-020-01746-2 |2 doi | |
| 035 | |a (DE-627)OLC2126735982 | ||
| 035 | |a (DE-He213)s00508-020-01746-2-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 100 | 1 | |a Ebbers, Meinolf |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Immunotherapy and vaccination against infectious diseases |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © The Author(s) 2020 | ||
| 520 | |a Summary Due to the overuse of antibiotics, infections, in particular those caused by multidrug-resistant bacteria, are becoming more and more frequent. Despite the worldwide introduction of antibiotic therapy, vaccines and constant improvements in hygiene, the burden of multidrug-resistant bacterial infections is increasing and is expected to rise in the future. The development of monoclonal therapeutic antibodies and specific immunomodulatory drugs represent new treatment options in the fight against infectious diseases. This article provides a brief overview of recent advances in immunomodulatory therapy and other strategies in the treatment of infectious disease. | ||
| 650 | 4 | |a Infectious disease | |
| 650 | 4 | |a Immunotherapy | |
| 650 | 4 | |a Immunomodulation | |
| 650 | 4 | |a Bacterial infections | |
| 650 | 4 | |a Monoclonal antibodies | |
| 700 | 1 | |a Hemmer, Christoph J. |4 aut | |
| 700 | 1 | |a Müller-Hilke, Brigitte |4 aut | |
| 700 | 1 | |a Reisinger, Emil C. |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Wiener klinische Wochenschrift |d Springer Vienna, 1888 |g 133(2020), 13-14 vom: 16. Dez., Seite 714-720 |w (DE-627)129460036 |w (DE-600)200462-8 |w (DE-576)014823977 |x 0043-5325 |7 nnns |
| 773 | 1 | 8 | |g volume:133 |g year:2020 |g number:13-14 |g day:16 |g month:12 |g pages:714-720 |
| 856 | 4 | 1 | |u https://doi.org/10.1007/s00508-020-01746-2 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a GBV_ILN_267 | ||
| 912 | |a GBV_ILN_2008 | ||
| 912 | |a GBV_ILN_4306 | ||
| 951 | |a AR | ||
| 952 | |d 133 |j 2020 |e 13-14 |b 16 |c 12 |h 714-720 | ||